Hanmi Pharm Co Ltd banner

Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 506 000 KRW 1.71% Market Closed
Market Cap: ₩6.5T

Wall St Price Targets

Price Forecast
Based on 19 analysts

+31% Upside
from ₩506 000 today

Hanmi Pharm Co Ltd (128940)’s 12-month stock price forecast through October 2027 has a consensus target of ₩663 000, implying 31% upside. The forecast is based on price targets from 19 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Hanmi Pharm Co Ltd yet.

Hanmi Pharm Co Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Hanmi Pharm Co Ltd's stock price target?
Price Target
663 000 KRW

According to Wall Street analysts, the average 1-year price target for Hanmi Pharm Co Ltd is 663 000 KRW with a low forecast of 474 700 KRW and a high forecast of 850 500 KRW.

What is the Revenue forecast for Hanmi Pharm Co Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Hanmi Pharm Co Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 8%.

What is the Operating Income forecast for Hanmi Pharm Co Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 8%.

What is the Pre-Tax Income forecast for Hanmi Pharm Co Ltd?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Hanmi Pharm Co Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 15%.

Back to Top